These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15454299)

  • 1. A novel formulation technique for metered dose inhaler (MDI) suspensions.
    Steckel H; Wehle S
    Int J Pharm; 2004 Oct; 284(1-2):75-82. PubMed ID: 15454299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
    Jones SA; Martin GP; Brown MB
    Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and evaluation of albuterol metered dose inhalers containing tetrafluoroethane (P134a), a non-CFC propellant.
    Tiwari D; Goldman D; Malick WA; Madan PL
    Pharm Dev Technol; 1998 May; 3(2):163-74. PubMed ID: 9653753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of "in-flight" laser diffraction to the particle size characterization of a model suspension metered dose inhaler.
    Pu Y; Kline LC; Berry J
    Drug Dev Ind Pharm; 2011 May; 37(5):552-8. PubMed ID: 21126224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An assessment of beclomethasone dipropionate clathrate formation in a model suspension metered dose inhaler.
    Bouhroum A; Burley JC; Champness NR; Toon RC; Jinks PA; Williams PM; Roberts CJ
    Int J Pharm; 2010 May; 391(1-2):98-106. PubMed ID: 20184946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
    Peyron ID; Britto IL; Benissan LB; Tardieu BZ
    Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility evaluation of metered-dose inhaler valve elastomers with tetrafluoroethane (P134a), a non-CFC propellant.
    Tiwari D; Goldman D; Dixit S; Malick WA; Madan PL
    Drug Dev Ind Pharm; 1998 Apr; 24(4):345-52. PubMed ID: 9876594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Formulation Factors on the Aerosol Performance of Suspension and Solution Metered Dose Inhalers: A Systematic Approach.
    Sheth P; Sandell D; Conti DS; Holt JT; Hickey AJ; Saluja B
    AAPS J; 2017 Sep; 19(5):1396-1410. PubMed ID: 28593514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in metered dose inhaler technology: formulation development.
    Myrdal PB; Sheth P; Stein SW
    AAPS PharmSciTech; 2014 Apr; 15(2):434-55. PubMed ID: 24452499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.
    Tarara TE; Hartman MS; Gill H; Kennedy AA; Weers JG
    Pharm Res; 2004 Sep; 21(9):1607-14. PubMed ID: 15497686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plume temperature emitted from metered dose inhalers.
    Brambilla G; Church T; Lewis D; Meakin B
    Int J Pharm; 2011 Feb; 405(1-2):9-15. PubMed ID: 21129465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
    Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
    Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isobutane driven salbutamol sulfate metered dose inhaler: formulation selection and respiratory tract absorption in guinea pigs].
    Ding L; Zhang JS
    Yao Xue Xue Bao; 2009 Sep; 44(9):1040-5. PubMed ID: 20055182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albuterol metered dose inhaler performance under hyperbaric pressures.
    Johnson GA; Gutti VR; Loyalka SK; O'Beirne KA; Cochran SK; Dale HM; Kracke GR
    Undersea Hyperb Med; 2009; 36(1):55-63. PubMed ID: 19341128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system.
    Ross DL; Gabrio BJ
    J Aerosol Med; 1999; 12(3):151-60. PubMed ID: 10623331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metered-dose inhaler formulations with beclomethasone-17,21-dipropionate using the ozone friendly propellant R 134a.
    Steckel H; Müller BW
    Eur J Pharm Biopharm; 1998 Jul; 46(1):77-83. PubMed ID: 9700025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of two methods to determine the solubility of compounds in aerosol propellants.
    Gupta A; Myrdal PB
    Int J Pharm; 2005 Mar; 292(1-2):201-9. PubMed ID: 15725567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers.
    Smyth HD; Beck VP; Williams D; Hickey AJ
    AAPS PharmSciTech; 2004 Feb; 5(1):E7. PubMed ID: 15198528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.